Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harrow Inc
(NQ:
HROW
)
38.92
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow Inc
< Previous
1
2
3
4
5
6
7
Next >
Home Depot, Beauty Health And 3 Stocks To Watch Heading Into Tuesday
November 14, 2023
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Recap: Harrow Q3 Earnings
November 13, 2023
Via
Benzinga
Harrow Announces Third Quarter 2023 Financial Results
November 13, 2023
From
Harrow, Inc.
Via
Business Wire
Harrow Health's Earnings Outlook
November 10, 2023
Via
Benzinga
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/30
May 30, 2023
Via
Investor Brand Network
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023
From
Harrow, Inc.
Via
Business Wire
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
October 24, 2023
From
Harrow, Inc.
Via
Business Wire
Harrow Health, Inc. Changes Corporate Name to Harrow, Inc.
September 29, 2023
From
Harrow Health, Inc.
Via
Business Wire
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
September 26, 2023
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Announces Second Quarter 2023 Financial Results
August 09, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Launches VIGAMOX® in the U.S.
July 31, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023
July 26, 2023
From
Harrow Health, Inc.
Via
Business Wire
Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected
July 19, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also...
Via
Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 19, 2023
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 19, 2023
Via
Benzinga
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results
July 19, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,...
Via
Benzinga
Why Shares of Harrow Health Are Jumping Wednesday
July 19, 2023
The company increased guidance, acquired a company, and had a stock sale.
Via
The Motley Fool
Why Harrow Health Stock Is Trading Higher Today?
July 19, 2023
Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH.
Via
Benzinga
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
July 19, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Harrow Prices $60 Million Public Offering of Common Stock
July 19, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Acquires Santen’s Branded Ophthalmic Portfolio
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Announces Proposed Public Offering of Common Stock
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023
May 17, 2023
From
Harrow
Via
Business Wire
NASDAQ:HROW Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties at Harrow Health, Inc
May 16, 2023
San Diego, CA -- (SBWIRE) -- 05/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Harrow Health, Inc.
Via
SBWire
Why Shares of Harrow Health Are Slumping Friday
May 12, 2023
The pharmaceutical company announced first-quarter earnings Thursday afternoon.
Via
The Motley Fool
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 12, 2023
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.